Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: A Study in Subjects With Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update in subjects with moderate atopic dermatitis has completed.
-
FDA approval · 2018-10-23FDA Approved: DESOXIMETASONE — Original Application (The J. Molner Company LLC)
FDA approved the original ANDA for desoximetasone, a topical corticosteroid, from The J. Molner Company LLC.
-
FDA approval · 2018-10-19FDA Approved: DUPIXENT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for DUPIXENT (dupilumab) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial evaluating various dupilumab dose regimens in adults with atopic dermatitis completed with posted results.
-
FDA approval · 2018-10-16FDA Approved: FLUOCINONIDE — Original Application (Encube Ethicals, Inc.)
FDA approved Fluocinonide under Encube Ethicals, Inc.'s Original Application (ANDA 211410), establishing regulatory approval for this topica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-10-12FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' original application for a generic Betamethasone Dipropionate topical product.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis [Phase 2]
Phase 2 pilot efficacy and safety study of AQX-1125 in Atopic Dermatitis completed with results posted in 2018.
-
FDA approval · 2018-10-04FDA Approved: CLOBETASOL PROPIONATE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved CLOBETASOL PROPIONATE as an original-application generic topical product. The approval holder is Taro Pharmaceuticals U.S.A., I…
-
FDA approval · 2018-09-28FDA Approved: DESOXIMETASONE — Original Application (Viona Pharmaceuticals Inc)
The FDA approved Viona Pharmaceuticals Inc.'s desoximetasone topical product as an original application, providing a generic version of the …
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial assessing efficacy and steroid-sparing potential of DGLA cream in moderate-to-severe atopic dermatitis completed.
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Topical Steroid Formulation and Wet Wraps [Phase 4]
Phase 4 trial update for a topical steroid formulation using wet wraps in dermatitis, atopic; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Phase 2 Study of KHK4577 [Phase 2]
Phase 2 study of KHK4577 for atopic dermatitis has been completed.
-
FDA approval · 2018-08-21FDA Approved: FLUOCINONIDE CREAM — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved a generic fluocinonide cream from Amneal Pharmaceuticals NY LLC (ANDA 210554).
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Sublingual Immunotherapy in Patients With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating sublingual immunotherapy in patients with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update for dupilumab in adults with extrinsic moderate-to-severe atopic dermatitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for RVT-501 in adults and adolescents with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating RVT-501 topical ointment in pediatric patients with atopic dermatitis has completed.
-
FDA approval · 2018-07-17FDA Approved: FLUOCINONIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the fluocinonide topical product from Zydus Lifesciences Limited via an Original Application, marking the first generic entry f…
-
CLINICAL_TRIALS withdrawal · 2018-07-06Clinical Trial Update: Pediatric Atopic Dermatitis (AD) Internet Survey [NA]
A pediatric internet survey trial in atopic dermatitis sponsored by Wake Forest University has been withdrawn.
-
FDA approval · 2018-06-27FDA Approved: METHYLPREDNISOLONE ACETATE — Original Application (Sagent Pharmaceuticals)
The FDA approved the original application for methylprednisolone acetate from Sagent Pharmaceuticals, enabling a generic topical corticoster…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Evaluating Treatment Resistant Dermatitis TaroIIR [Phase 4]
Phase 4 clinical trial update for treatment-resistant dermatitis (Atopic Dermatitis and Psoriasis) completed with results posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2018-06-12Clinical Trial Update: Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy [NA]
Clinical trial evaluating skin barrier dysfunction in infants at high risk of atopy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants
A completed clinical trial from Indonesia University examining how filaggrin and FADS gene variants influence PUFA concentrations and their …
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for Pf-04965842 in adults with moderate-to-severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2018-05-15Clinical Trial Update: A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating Orvepitant for pruritus associated with atopic dermatitis has been withdrawn.